TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $111,000 | +122.0% | 6,283 | +123.0% | 0.00% | – |
| Q2 2023 | $50,000 | +212.5% | 2,817 | +122.0% | 0.00% | – |
| Q1 2023 | $16,000 | -62.8% | 1,269 | -57.0% | 0.00% | – |
| Q4 2022 | $43,000 | +437.5% | 2,953 | +566.6% | 0.00% | – |
| Q3 2022 | $8,000 | +100.0% | 443 | +37.6% | 0.00% | – |
| Q2 2022 | $4,000 | -69.2% | 322 | -56.3% | 0.00% | – |
| Q1 2022 | $13,000 | -73.5% | 737 | -65.7% | 0.00% | – |
| Q4 2021 | $49,000 | +145.0% | 2,147 | +132.1% | 0.00% | – |
| Q3 2021 | $20,000 | +17.6% | 925 | +60.3% | 0.00% | – |
| Q2 2021 | $17,000 | -64.6% | 577 | -60.7% | 0.00% | – |
| Q1 2021 | $48,000 | +41.2% | 1,470 | +78.2% | 0.00% | – |
| Q4 2020 | $34,000 | – | 825 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |